文献速递主动脉疾病

复杂腹主动脉瘤开窗腔内修复术后近端封闭区扩张

Proximal seal dilatation following fenestrated endovascular repair for complex abdominal aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2022-01-04

本研究纳入2008至2018年荷兰两家教学医院连续84例接受开窗腔内修复(FEVAR)的肾旁/肾上腹主动脉瘤患者,评估近端封闭区扩张(PSD)动态变化及临床意义。结果显示术后第一年PSD为1.7 mm,随后减速至每年0.9 mm;仅1例(1.2%)发生近端封闭相关不良事件(IA型内漏)。作者认为PSD临床影响在植入后早期似乎有限,但需进一步研究长期影响。

要点

  • FEVAR术后第一年近端封闭区扩张1.7 mm,第二年减速至0.9 mm/年。
  • 1年时超过10%的PSD发生于22例(27%),与支架移植物 Oversizing 及目标血管数量较少相关。
  • 研究期间仅1例(1.2%)发生近端封闭相关不良事件(IA型内漏)。

核心结论

  • FEVAR术后存在近端封闭区扩张,第一年速率较快、其后减速,与标准肾下EVAR术后瘤颈扩张相似。
  • 尽管PSD在植入后最初几年的临床意义似乎有限,仍需进一步研究评估其对FEVAR长期结局的影响。

研究设计与样本

  • 研究纳入2008至2018年荷兰两家大型教学医院连续接受Zenith Fenestrated Endovascular Graft(Cook Medical)行开窗腔内修复的肾旁/肾上腹主动脉瘤患者,共84例。
  • 主要结局为随时间变化的近端封闭区扩张,采用线性混合效应模型确定;次要结局包括早期PSD的相关因素及覆盖支架与裸支架水平主动脉扩张差异。

主要发现

  • 中位计算机断层血管造影随访时间为24.5个月(四分位距17-42个月),最大动脉瘤直径为60.1 mm(四分位距56.9-67.2 mm)。
  • 基线近端封闭区平均直径为26.2 mm(标准差±2.8 mm),支架平均 Oversizing 为20.1%(标准差±9.1%),近端封闭区平均长度为29.5 mm(标准差±11.7 mm)。
  • 第一年近端封闭区扩张为1.7 mm(95%置信区间1.4-2.1 mm),其后减速(第二年0.9 mm/年;95%置信区间0.7-1.1 mm/年)。
  • 1年时超过10%的PSD发生于22例(27%),与支架移植物 Oversizing 相关(比值比1.1;95%置信区间1.03-1.2;P = .008),与目标血管数量较少相关(四开窗 vs 两开窗:比值比0.13;95%置信区间0.02-0.74;P = .029)。
  • 末次影像检查时,覆盖支架水平扩张差异高于裸支架水平(3.0 mm [四分位距1.3-5.1 mm] vs 1.6 mm [四分位距0.8-2.5 mm];P < .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者结论指出需进一步研究以评估PSD对FEVAR长期结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although proximal neck dilatation following infrarenal endovascular aneurysm repair (EVAR) is common and is associated with proximal graft failure, little is known about sealing zone dilatation and its clinical relevance following fenestrated EVAR (FEVAR). We studied proximal seal dilatation (PSD) dynamics following FEVAR and assessed its clinical significance. METHODS: We included all consecutive patients treated for a juxta-/supra-renal aneurysm with fenestrated EVAR using the Zenith Fenestrated Endovascular Graft (Cook Medical, Bloomington, Ind) from 2008 to 2018 in two large teaching hospitals in the Netherlands. The primary outcome was PSD over time and was determined using a linear mixed-effects model. Secondary outcomes included associations for early PSD and difference in aortic dilatation at the level of the covered stent compared with the bare stent. Proximal seal-related adverse events were also obtained. RESULTS: Our cohort included 84 patients with a median computed tomography angiography follow-up time of 24.5 months (interquartile range [IQR], 17-42 months). Maximum aneurysm diameter was 60.1 mm (IQR, 56.9-67.2 mm). Mean proximal seal diameter at baseline was 26.2 mm (standard deviation [SD], ±2.8 mm), mean stent oversizing was 20.1% (SD, ±9.1%), and mean proximal seal length was 29.5 mm (SD, ±11.7 mm). Proximal seal dilatation of 1.7 mm (95% confidence interval [CI], 1.4-2.1 mm) was found in the first year, decelerating thereafter (second year, 0.9 mm/year; 95% CI, 0.7-1.1 mm/y). Over 10% PSD at 1 year occurred in 22 patients (27%) and was associated with stent graft oversizing (odds ratio, 1.1; 95% CI, 1.03-1.2; P = .008) and a lower number of target vessels (four fenestrations/ref two fenestrations: odds ratio, 0.13; 95% CI, 0.02-0.74; P = .029). At last available imaging, dilatation difference was higher at the level of the covered stent compared with the bare stent (3.0 mm [IQR, 1.3-5.1 mm] vs 1.6 mm [IQR, 0.8-2.5 mm]; P < .001). During the study period, only one patient (1.2%) developed a proximal seal-related adverse event (type IA endoleak). CONCLUSIONS: PSD is present following FEVAR, occurring at a faster rate in the first year and subsequently decelerating thereafter, similarly to neck dilatation after standard infrarenal EVAR. Although its clinical implication seems to remain limited in the first years following implantation, further research is required to assess the effect of PSD on long-term FEVAR outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rastogi V, de Bruin JL, Varkevisser RRB, et al. Proximal seal dilatation following fenestrated endovascular repair for complex abdominal aortic aneurysms. J Vasc Surg. 2022. PMID: 34990782. doi:10.1016/j.jvs.2021.12.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。